Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 15Gastrointestinal 6Other hematologic neoplasm 5Thoracic 2Head & Neck 2Classical hematology 2Sarcoma 1Other neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 615Head and Neck Neoplasms 596Nasopharyngeal Carcinoma 230Thyroid Neoplasms 148Oropharyngeal Neoplasms 104Carcinoma, Squamous Cell 89Salivary Gland Neoplasms 88Mouth Neoplasms 87Nasopharyngeal Neoplasms 79Recurrence 66Carcinoma, Non-Small-Cell Lung 64Laryngeal Neoplasms 60Neoplasm Metastasis 58Neoplasms 49Hypopharyngeal Neoplasms 45Thyroid Carcinoma, Anaplastic 42Thyroid Cancer, Papillary 42Melanoma 38Breast Neoplasms 36Lung Neoplasms 33Adenocarcinoma, Follicular 33Carcinoma 32Tongue Neoplasms 30Sarcoma 29Stomatitis 28Uterine Cervical Neoplasms 27Colorectal Neoplasms 27Carcinoma, Medullary 24Ovarian Neoplasms 23Esophageal Neoplasms 23

Interventions

toripalimab 1nimotuzumab 1Neoadjuvant Therapy 1Immunotherapy 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Pathologic Complete Response × Head & Neck × Clear all
NCT07353723 2026-01-20

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Tang-Du Hospital

Phase 2 Recruiting
10 enrolled
Head & Neck

Pathologic Complete Response, Head and Neck Neoplasms

NCT06811844 2025-07-01

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting
208 enrolled
Head & Neck

Pathologic Complete Response, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡